Correspondence

Lord Henley's response to ACMD on D2PM

A response to the Advisory Council on the Misuse of Drugs' further advice on D2PM.

Documents

Response on diphenylprolinol (D2PM) and diphenylmethylpyrrolidine

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

A response to the Advisory Council on the Misuse of Drugs’ further advice on D2PM and diphenylmethylpyrrolidine.

Published 26 March 2013